Work

Pomalidomide for the treatment of relapsed and refractory multiple myeloma

Year: 2014

Type: article

Source: Expert Opinion on Orphan Drugs

DOI: 10.1517/21678707.2014.953480

Authors: Anna Guidetti, Claudia Paba Prada, Jacob P Laubach, Cindy Varga, Michelle E Maglio, Mary McKenney, Deborah Doss, Robert L Schlossman, Constantine Mitsiades, Teru Hideshima, Güllü T Görgün, Irene M Ghobrial, Noopur Raje, Nikhil Munshi, Kenneth C Anderson, Paul G Richardson

Institutions: University of Milan, Harvard University, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Dana-Farber Brigham Cancer Center, Massachusetts General Hospital, Dana-Farber/Harvard Cancer Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Celgene

OpenAlex ID: W2085533944

FWCI:

Cites: 97

Cited by: 1

Related to: 10